The company's Q3 FY20 consolidated net loss increased to Rs 835 crore against a loss of Rs 151.7 crore in the same quarter last fiscal
Shares of Lupin fell 3 percent in the early trade on February 7 after company's net loss widened in the quarter-ended December 2019.
The company's Q3 FY20 consolidated net loss increased to Rs 835 crore against a loss of Rs 151.7 crore in the same quarter last fiscal.
Revenue fell 4.5 percent year-on-year to Rs 3,769 crore.
Earnings before interest, tax, depreciation and amortisation (EBITDA) plummeted 37 percent to Rs 429 crore. EBITDA margin was down at 11.4 percent versus 17.3 percent YoY.
Other income rose Rs 93.5 crore versus Rs 40.2 crore YoY.
CLSA | Rating: Sell | Target: Cut to Rs 600 from Rs 690 per share
The company's EBITDA margin comes in at multi-year lows. However, the execution is the key and a slip could pose further earnings risk.
It cut FY21-22 EPS estimates by 12-14 percent.
Jefferies | Rating: Underperform | Target: Cut to Rs 600 from Rs 620 per share
The company has reported Q3F Y20 resuls which was well below expectations.
The US revenue was flat QoQ and India growth was also below peers (9 percent).
The near-term outlook is weak with key product launches delayed to FY21.
At 09:18 hours Lupin was quoting at Rs 707.00, down Rs 13.50, or 1.87 percent on the BSE.Exclusive offer: Use code "BUDGET2020" and get Moneycontrol Pro's Subscription for as little as Rs 333/- for the first year.
